KENACORT RETARD 40 mg/1 ml, suspension for injection bottle, 1 ml
Active ingredients: Triamcinolone acetonide
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Suspension for injectionbottle, 1 mlintraarticulaire;intralésionnelle;intramusculaire
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- KENACORT RETARD 40 mg/1 ml, suspension injectable
- Pharmaceutical form
- suspension injectable
- Route of administration
- intraarticulaire;intralésionnelle;intramusculaire
- Presentation description
- 1 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- BRISTOL MYERS SQUIBB
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65061047CIP73024344CIP133400930243442Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTONIDE DE TRIAMCINOLONEsuspension | 40,0 mg · 1 ml de suspension injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.